About the Experts: Lester Lee, M.D., is a regenerative medicine physician specializing in hormone replacement therapy
Following the loading phase, maintenance injections are given every two to three months for life, as pernicious anaemia is a chronic condition requiring ongoing treatment
Vitamin Injections can optimize repair, recovery, and rehydration on the cellular level
CagriSema is investigational under FDA review with a decision expected in 2026, not yet approved [4]
not clinically significant at standard doses Who should avoid TB-500 Active malignancy (precautionary) Pregnancy and breastfeeding Known peptide sensitivity Anyone unable to maintain sterile injection technique Storage Lyophilised powder: freeze at -20 C immediately on receipt
Critical Considerations: Investigational Use Only: These doses were used ONLY within specific clinical studies